TP53 and Miyoshi myopathy: Remarkably, ectopic expression of miRNA-137 increased the sensibility of the MM cells to bortezomib (BTZ) through augmenting p53 expression and decreasing ataxia telangiectasia mutated/checkpoint kinase 2DNA repair pathway (ATM/Chk2).